Capricor Therapeutics (CAPR) Total Debt (2010 - 2024)
Capricor Therapeutics' (CAPR) quarterly Total Debt came in at $3.4 million in Q3 2024, little changed year-on-year from $3.4 million in Q4 2023, and little changed quarter-over-quarter from $3.4 million in Q2 2024.
Capricor Therapeutics (CAPR) Total Debt (2010 - 2024) Analysis & Trends
Capricor Therapeutics' Total Debt history runs 15 years deep, the most recent figure standing at $3.4 million for Q3 2024.
- On a quarterly basis, Total Debt changed 0.0% year-over-year to $3.4 million in Q3 2024; TTM through Sep 2024 was $3.4 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $3.4 million, down 2.57% from the prior year.
- Total Debt held at $3.4 million in Q3 2024 per CAPR's latest filing, from $3.4 million in the prior quarter.
- Across five years, Total Debt topped out at $4.0 million in Q4 2021 and bottomed at $35469.0 in Q1 2021.
- The 5-year median for Total Debt is $3.4 million (2020), against an average of $2.9 million.
- Across the five-year window, Total Debt plunged 98.95% in 2021 and soared 11039.61% in 2022, its largest moves.
- Year by year, Total Debt stood at $71471.0 in 2020, then soared by 5462.6% to $4.0 million in 2021, then dropped by 12.83% to $3.5 million in 2022, then slipped by 2.57% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024.
- Per Business Quant, the three latest CAPR Total Debt figures stand at $3.4 million (Q3 2024), $3.4 million (Q2 2024), and $3.4 million (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.95 Mn |
| Dec 31, 2021 | 3.98 Mn |
| Mar 31, 2021 | 35,469.00 |
| Dec 31, 2020 | 71,471.00 |
| Sep 30, 2020 | 3.38 Mn |
| Jun 30, 2020 | 178,233.00 |
| Mar 31, 2020 | 3.38 Mn |
| Dec 31, 2019 | 3.38 Mn |
| Sep 30, 2019 | 3.38 Mn |
| Jun 30, 2019 | 3.38 Mn |